Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Lambertini, M
  • Campbell, C
  • Bines, J
  • Korde, L
  • Delso, MA Izquierdo
  • Fumagalli, D
  • Pritchard, Kathleen
  • Wolff, A
  • Jackisch, C
  • Lang, I
  • Untch, M
  • Smith, I
  • Boyle, FM
  • Xu, B
  • Barrios, CH
  • Baselga, J
  • Moreno-Aspitia, A
  • Piccart, M
  • Gelber, R
  • De Azambuja, E

publication date

  • September 1, 2017